CRISPR Enables In Vivo CAR T Cell Production In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing March 30, 2026 2 min The Medicine Maker Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions